Stay updated on MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.

Latest updates to the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page has updated the number of study locations from 19 to 21 and added specific details for new locations in Colorado and Delaware.SummaryDifference2%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now indicates that a study has expanded to 19 locations and is actively recruiting participants, with specific details about a new site in Baltimore, Maryland, and a contact person at Texas Oncology-Fort Worth Cancer Center.SummaryDifference2%
- Check25 days agoChange DetectedThe page now lists 18 study locations, including a new location in Hackensack, New Jersey, and updates the date to 2025-02-21. The previous count of locations was 17.SummaryDifference3%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe page has updated the number of study locations from 15 to 17 and added new locations in New York and Pennsylvania. Additionally, there are new dates for the study's timeline.SummaryDifference5%
- Check47 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.